ReviewProbiotics and antimicrobial proteins2026
Postbiotics and Parabiotics in Veterinary Medicine: A Market Overview.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cecal microbiota transportation, social stress, and injurious behaviors in chickens - A review.Poultry science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postbiotics and parabiotics (PP) are innovative concepts in veterinary medicine that have garnered substantial interest owing to their unique properties and potential benefits. PP offers a promising alternative to live bacteria, demonstrating properties such as prebiotic, immunomodulatory, antimicrobial, anti-inflammatory, antioxidant, and anticancer effects, while potentially mitigating some of the common challenges associated with live bacterial applications. PP products are manufactured and commercially employed in livestock, poultry, and pets. Moreover, postbiotic-based commercial products have exhibited a diverse range of beneficial effects including enhanced gut health and microbiota, strengthened immune modulation, stress mitigation, and improved animal production. Moreover, their antimicrobial and anti-inflammatory properties make them viable dietary supplements or additives, potentially replacing antibiotics and addressing the growing concern of antibiotic resistance in the livestock industry. This work reviews the commercial applications of PP in animal nutrition and therapeutics, including in poultry, cattle, sheep, horses, and pet animals. The growing demand for PP products shows that we need to keep researching to find new uses for PP.
Indexed as
Identifiers
40889059What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.